| Identification | Back Directory | [Name]
6-CARBOXY-2,4-DIHYDROXYPYRIMIDINE MONOSODIUM SALT | [CAS]
154-85-8 | [Synonyms]
ate(1:1:1)
sodiumorotatehydrate
OROTIC ACID, NA SALT
orotic acid monosodium
Sodiumorotateanhydrous
orotic acid sodium salt
monosodiumorolatehydrate
OROTIC ACID MONOSODIUM SALT
oroticacid,sodiumsalt,hydrate(1:1:1)
URACIL-6-CARBOXYLIC ACID MONOSODIUM SALT
Sodium 2,6-dihydroxypyrimidine-4-carboxylate
6-CARBOXY-2,4-DIHYDROXYPYRIMIDINE MONOSODIUM SALT
6-Carboxy-2,4-dihydroxypyrimidine monosodium salt ,99%
Sodium 2,6-Dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate
6-CARBOXY-2,4-DIHYDROXYPYRIMIDINE MONOSODIUM SALT USP/EP/BP
sodium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate
1,2,3,6-Tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic acid sodium salt
4-pyrimidinecarboxylicacid,1,2,3,6-tetrahydro-2,6-dioxo-,sodiumsalt,hydr
4-PyriMidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, MonosodiuM salt | [EINECS(EC#)]
205-834-0 | [Molecular Formula]
C5H3N2NaO4 | [MDL Number]
MFCD00050920 | [MOL File]
154-85-8.mol | [Molecular Weight]
178.08 |
| Hazard Information | Back Directory | [Chemical Properties]
White powder | [Uses]
Orotic Acid Monosodium Salt is used in the formation of a complex with lanthanium(III) which displats cytotoxic activity on different tumor cell lines.Also, it is the unlabeled form of Orotic Acid-15N2 Monosodium Salt (O691517), which is an intermediate used in the synthesis of Orotic Acid-15N2 Monohydrate (O691504), which is a labeled analogue of Orotic Acid Monohydrade (O691500), which is used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment. | [Definition]
ChEBI: An organic sodium salt comprising equal numbers of sodium and orotate ions. |
|
| Company Name: |
Spectrum Chemical Manufacturing Corp.
|
| Tel: |
021-021-021-67601398-809-809-809 15221380277 |
| Website: |
www.spectrumchemical.com/oa_html/index.jsp?minisite=10020&respid=22372&language=us |
|